SIMULTANEOUS ESTIMATION, VALIDATION, AND FORCED DEGRADATION STUDIES OF BETAHISTINE DIHYDROCHLORIDE AND DOMPERIDONE IN A PHARMACEUTICAL DOSAGE FORM USING RP-HPLC METHOD
DOI:
https://doi.org/10.22159/ajpcr.2018.v11i10.26132Keywords:
Betahistine dihydrochloride, Domperidone, Reverse-phase high-performance liquid chromatography, Degradation, ValidationAbstract
Objective: This study describes the stability-indicating reverse-phase high-performance liquid chromatography (RP-HPLC) method for simultaneous estimation of betahistine dihydrochloride and domperidone in pharmaceutical dosage forms.
Methods: The proposed RP-HPLC method was developed using Shimadzu Prominence-i LC-2030 HPLC system equipped with UV detector and chromatographic operation was carried on Shim-pack C18 (250 mm×4.6 mm, 5 μ) column at a flow rate of 1 ml/min and the run time was 10 min. The mobile phase consisted of methanol and water in the ratio of 80:20% v/v and eluents were scanned using a UV detector at 244 nm.
Results: The retention time of betahistine dihydrochloride and domperidone was found to be 2.3 and 3.6 min, respectively. A linearity response was observed in the concentration range of 9.6 μg/ml–22.4 μg/ml for betahistine dihydrochloride and 6–14 μg/ml for domperidone, respectively. Limit of detection and limit of quantification for betahistine dihydrochloride were 0.52 μg/ml and 1.58 μg/ml and for domperidone are 0.64 μg/ml and 1.94 μg/ml, respectively.
Conclusion: The stability-indicating method was developed by subjecting drugs to stress conditions such as acid and base hydrolysis, oxidation, photo and thermal degradation, and degraded products formed were resolved successfully from samples.
Downloads
References
O’ Neil MJ, editor. Merck Index. 14th ed. White House Station NJ: Merck and Co. Inc.; 2005. p. 1177
Govt of India. Indian Pharmacopoeia. Vol. II, 6th ed. New Delhi: The Controller of Publication, Govt of India; 2010. p. 897-8.
London Medicines and Health Care Product Regulatory Agency. British Pharmacopoeia. Vol. I. London: Stationary Office, London Medicines and Health Care Product Regulatory Agency; 2010. p. 254-5.
Council of Europe. European Pharmacopoeia 6.0. Vol. II. 6th ed. Starboary: Council of Europe; 2008. p. 1292.
U.S. Pharmacopoeia/NF. Vol II. Twinbrook Pathway Rockvillae: The United States Pharmacpoeial Convention; 2013. p. 2635.
Aboutaleb AE, Abdel-Rahman SI, Ahmed MO, Younis MA. Design and evaluation of domperidone sublingual tablets. Int J Pharm Pharm Sci ISSN 2016;8:975-1491.
Praseetha K, kathirvel SR. Development and validation of RP-HPLC method for betahistine dihydrochloride in pharmaceutical dosage form. J Pharm Search 2014;9:621-5370.
Suparna S, Kumar SA. RP-HPLC method development and validation of domperidone in solid dosage form. Pharma Innov 2012;1:2277-7695.
Moinuddin M, Rahaman A, Yadav R, Battu R. Development and validation of RP-HPLC for simultaneous estimation of rosuvastatin calcium and fenofibrate in tablet dosage form. Int J Pharm Pharm Sci 2012;4 Suppl 3:975-1491.
Patil R, Deshmukh T, Patil V. Stability indicating HPLC method for dapoxetinehcl in bulk and in formulation. Int J Pharm Pharm Sci 2014;6:975-1491.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
